Sanctuary Advisors LLC Purchases New Holdings in Exponent, Inc. (NASDAQ:EXPO)

Sanctuary Advisors LLC acquired a new stake in Exponent, Inc. (NASDAQ:EXPO) during the second quarter, according to its most recent filing with the SEC. The firm acquired 17,897 shares of the business services provider’s stock, valued at approximately $1,704,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Inspire Advisors LLC lifted its stake in shares of Exponent by 1.3% during the second quarter. Inspire Advisors LLC now owns 7,615 shares of the business services provider’s stock valued at $724,000 after acquiring an additional 98 shares during the period. Caprock Group LLC lifted its position in Exponent by 4.2% during the 2nd quarter. Caprock Group LLC now owns 3,296 shares of the business services provider’s stock valued at $314,000 after purchasing an additional 134 shares during the period. GAMMA Investing LLC boosted its stake in shares of Exponent by 67.7% in the 2nd quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 153 shares during the last quarter. Retirement Systems of Alabama grew its position in shares of Exponent by 0.3% during the 1st quarter. Retirement Systems of Alabama now owns 63,568 shares of the business services provider’s stock worth $5,256,000 after buying an additional 167 shares during the period. Finally, Raymond James Trust N.A. raised its stake in shares of Exponent by 2.8% during the second quarter. Raymond James Trust N.A. now owns 6,230 shares of the business services provider’s stock worth $593,000 after buying an additional 172 shares during the last quarter. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Trading Down 0.4 %

NASDAQ EXPO opened at $112.16 on Wednesday. Exponent, Inc. has a 12 month low of $64.61 and a 12 month high of $115.61. The stock has a 50-day simple moving average of $107.31 and a 200 day simple moving average of $97.59. The company has a market capitalization of $5.69 billion, a PE ratio of 56.65 and a beta of 0.66.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The company had revenue of $132.43 million during the quarter, compared to analysts’ expectations of $130.83 million. During the same period in the prior year, the business posted $0.50 EPS. Exponent’s revenue was up 2.1% on a year-over-year basis. As a group, sell-side analysts predict that Exponent, Inc. will post 2.04 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were given a dividend of $0.28 per share. The ex-dividend date was Friday, September 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.00%. Exponent’s dividend payout ratio is 56.57%.

Wall Street Analysts Forecast Growth

Separately, Truist Financial reaffirmed a “buy” rating and issued a $120.00 price objective (up from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Insider Activity

In related news, VP John Pye sold 3,956 shares of the firm’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total transaction of $415,380.00. Following the sale, the vice president now owns 28,422 shares of the company’s stock, valued at approximately $2,984,310. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 2.10% of the stock is owned by company insiders.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.